These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 2658828

  • 1. [Current status of CDDP analogs in gynecologic malignancies].
    Yakushiji M, Nishimura H.
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1393-8. PubMed ID: 2658828
    [Abstract] [Full Text] [Related]

  • 2. [Phase III study of DWA2114R for ovarian cancer].
    Kato T, Yakushiji M, Nishimura H, Terashima Y, Sasaki H, Yamabe T, Yajima A, Fujimoto S, Hashimoto M, Nishiya I.
    Gan To Kagaku Ryoho; 1992 Aug; 19(9):1285-93. PubMed ID: 1503482
    [Abstract] [Full Text] [Related]

  • 3. [Phase III study of carboplatin in ovarian cancer].
    Kato T, Nishimura H, Yamabe T, Terashima Y, Kasamatsu T, Hirabayashi K, Nishiya I, Yajima A, Takamizawa H, Tsutsui F.
    Gan To Kagaku Ryoho; 1988 Aug; 15(8):2297-304. PubMed ID: 3044276
    [Abstract] [Full Text] [Related]

  • 4. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.
    Thigpen T, Vance R, Puneky L, Khansur T.
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816
    [Abstract] [Full Text] [Related]

  • 5. [Consecutive low-dose cisplatin-based chemotherapy for gynecologic malignancies].
    Shimizu Y.
    Gan To Kagaku Ryoho; 1997 Feb; 24(4):431-8. PubMed ID: 9063480
    [Abstract] [Full Text] [Related]

  • 6. [Development of carboplatin].
    Tsukagoshi S.
    Gan To Kagaku Ryoho; 1990 Sep; 17(9):1949-58. PubMed ID: 2203318
    [Abstract] [Full Text] [Related]

  • 7. [Second-generation cisplatin analogs].
    Ariyoshi Y, Ota K.
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1043-50. PubMed ID: 3551846
    [Abstract] [Full Text] [Related]

  • 8. [Phase II study of 254-S (cis-diammine glycolato platinum) for gynecological cancer].
    Kato T, Nishimura H, Yakushiji M, Noda K, Terashima Y, Takeuchi S, Takamizawa H, Suzuki M, Arai M, Ota M.
    Gan To Kagaku Ryoho; 1992 May; 19(5):695-701. PubMed ID: 1580643
    [Abstract] [Full Text] [Related]

  • 9. Carboplatin/paclitaxel versus cisplatin/paclitaxel as first-line chemotherapy in advanced ovarian cancer: an interim analysis of a randomized phase III trial of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group.
    du Bois A, Lück HJ, Meier W, Möbus V, Costa S, Richter B, Warm M, Bauknecht T, Schröder W, Olbricht S, Nitz U, Jackisch C.
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-44-S15-52. PubMed ID: 9346222
    [Abstract] [Full Text] [Related]

  • 10. [Antitumor activity of platinum analogs against human ovarian tumors heterotransplanted into nude mice].
    Sawada M, Ozaki M, Hongo J, Hirota Y, Inagaki M, Taniguchi H, Tateishi R, Mori Y.
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):693-8. PubMed ID: 3548596
    [Abstract] [Full Text] [Related]

  • 11. ICON 2 and ICON 3 data in previously untreated ovarian cancer: results to date.
    Harper P.
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-23-S15-25. PubMed ID: 9346217
    [Abstract] [Full Text] [Related]

  • 12. Carboplatin versus cisplatin in ovarian cancer.
    Alberts DS.
    Semin Oncol; 1995 Oct; 22(5 Suppl 12):88-90. PubMed ID: 7481869
    [Abstract] [Full Text] [Related]

  • 13. A phase I and pharmacokinetic study of diamminecyclobutane-dicarboxylatoplatinum (NSC 241240).
    Curt GA, Grygiel JJ, Corden BJ, Ozols RF, Weiss RB, Tell DT, Myers CE, Collins JM.
    Cancer Res; 1983 Sep; 43(9):4470-3. PubMed ID: 6347373
    [Abstract] [Full Text] [Related]

  • 14. [Preclinical and clinical evaluation of toxicity and antitumor activity of cisplatin analogues].
    Ariyoshi Y, Ota K.
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1379-85. PubMed ID: 2658826
    [Abstract] [Full Text] [Related]

  • 15. [Combination chemotherapy of ovarian cancer with cisplatinum, aclarubicin and tegafur].
    Wada Y, Suzuki M, Shinagawa S, Saito Y, Nishiya I, Maki M, Yajima A, Hiroi M, Sato A.
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2589-94. PubMed ID: 2505683
    [Abstract] [Full Text] [Related]

  • 16. [Experimental evaluation of cisplatin analogous in urogenital cancer].
    Machida T, Akasaka Y.
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1386-92. PubMed ID: 2658827
    [Abstract] [Full Text] [Related]

  • 17. [Comparative studies of the antitumor activities of CDDP and the analogs--using gynecological carcinomas transplanted into nude mice].
    Suzumori K, Yasui Y, Suzumori K, Yagami Y.
    Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):387-91. PubMed ID: 2649007
    [Abstract] [Full Text] [Related]

  • 18. Recent updates in the clinical use of platinum compounds for the treatment of gynecologic cancers.
    Muggia FM.
    Semin Oncol; 2004 Dec; 31(6 Suppl 14):17-24. PubMed ID: 15726530
    [Abstract] [Full Text] [Related]

  • 19. [Phase II study of carboplatin in ovarian cancer].
    Kato T, Nishimura H, Yamabe T, Terashima Y, Kasamatsu T, Hirabayashi K, Nishiya I, Yajima A, Takamizawa H, Tsutsui F.
    Gan To Kagaku Ryoho; 1988 Aug; 15(8):2291-6. PubMed ID: 3044275
    [Abstract] [Full Text] [Related]

  • 20. Cisplatin sensitivity of ovarian cancer in the histoculture drug response assay correlates to clinical response to combination chemotherapy with cisplatin, doxorubicin and cyclophosphamide.
    Ohie S, Udagawa Y, Kozu A, Komuro Y, Aoki D, Nozawa S, Moossa AR, Hoffman RM.
    Anticancer Res; 2000 Aug; 20(3B):2049-54. PubMed ID: 10928150
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.